Ubs Group Ag Alphatec Holdings, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Alphatec Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,211,388 shares of ATEC stock, worth $16.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,211,388

Previous 297,836 306.73%

Holding current value

$16.3 Million

Previous $3.02 Million 345.23%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$9.43 - $13.03 $8.61 Million - $11.9 Million	913,552 Added 306.73%	1,211,388 $13.4 Million
Q1 2025 May 13, 2025	SELL	$9.06 - $12.53 $1.59 Million - $2.21 Million	-175,993 Reduced 37.14%	297,836 $3.02 Million
Q4 2024 Feb 14, 2025	BUY	$4.98 - $10.48 $671,139 - $1.41 Million	134,767 Added 39.75%	473,829 $4.35 Million
Q3 2024 Nov 14, 2024	BUY	$5.45 - $11.87 $49,535 - $107,886	9,089 Added 2.75%	339,062 $1.89 Million
Q2 2024 Aug 13, 2024	BUY	$9.49 - $14.26 $1.54 Million - $2.32 Million	162,775 Added 97.35%	329,973 $3.45 Million
Q1 2024 May 13, 2024	BUY	$12.8 - $16.78 $528,102 - $692,309	41,258 Added 32.76%	167,198 $2.31 Million
Q4 2023 Feb 09, 2024	BUY	$8.89 - $15.36 $561,634 - $970,383	63,176 Added 100.66%	125,940 $1.9 Million
Q3 2023 Nov 09, 2023	SELL	$12.4 - $18.8 $55,626 - $84,336	-4,486 Reduced 6.67%	62,764 $814,000
Q2 2023 Aug 11, 2023	BUY	$14.32 - $18.03 $357,398 - $449,992	24,958 Added 59.01%	67,250 $1.21 Million
Q1 2023 May 12, 2023	BUY	$11.83 - $16.02 $86,264 - $116,817	7,292 Added 20.83%	42,292 $659,000
Q4 2022 Feb 08, 2023	BUY	$8.91 - $12.35 $209,545 - $290,447	23,518 Added 204.82%	35,000 $432,000
Q3 2022 Nov 10, 2022	SELL	$6.57 - $9.74 $354 - $525	-54 Reduced 0.47%	11,482 $101,000
Q2 2022 Aug 10, 2022	SELL	$6.36 - $13.08 $74,895 - $154,030	-11,776 Reduced 50.51%	11,536 $75,000
Q1 2022 May 16, 2022	SELL	$9.45 - $12.85 $136,968 - $186,247	-14,494 Reduced 38.34%	23,312 $268,000
Q4 2021 Feb 14, 2022	BUY	$10.57 - $13.23 $271,469 - $339,786	25,683 Added 211.85%	37,806 $432,000
Q3 2021 Nov 15, 2021	SELL	$11.83 - $15.79 $430,777 - $574,977	-36,414 Reduced 75.02%	12,123 $147,000
Q2 2021 Aug 13, 2021	SELL	$13.75 - $17.6 $280,252 - $358,723	-20,382 Reduced 29.57%	48,537 $744,000
Q1 2021 May 12, 2021	SELL	$13.13 - $18.78 $80,762 - $115,515	-6,151 Reduced 8.19%	68,919 $1.09 Million
Q4 2020 Feb 11, 2021	SELL	$6.37 - $14.52 $8,503 - $19,384	-1,335 Reduced 1.75%	75,070 $1.09 Million
Q3 2020 Nov 12, 2020	SELL	$4.43 - $6.94 $81,658 - $127,925	-18,433 Reduced 19.44%	76,405 $507,000
Q2 2020 Jul 31, 2020	SELL	$3.05 - $5.59 $5,767 - $10,570	-1,891 Reduced 1.95%	94,838 $446,000
Q1 2020 May 01, 2020	SELL	$2.26 - $7.47 $86,596 - $286,227	-38,317 Reduced 28.37%	96,729 $334,000
Q4 2019 Feb 14, 2020	BUY	$4.77 - $7.65 $149,649 - $240,003	31,373 Added 30.26%	135,046 $958,000
Q3 2019 Nov 14, 2019	SELL	$4.27 - $6.22 $179,596 - $261,613	-42,060 Reduced 28.86%	103,673 $521,000
Q2 2019 Aug 14, 2019	BUY	$2.6 - $4.77 $9,578 - $17,572	3,684 Added 2.59%	145,733 $661,000
Q1 2019 May 14, 2019	BUY	$1.19 - $2.92 $85,024 - $208,631	71,449 Added 101.2%	142,049 $376,000
Q4 2018 Feb 14, 2019	BUY	$2.17 - $3.28 $20,673 - $31,248	9,527 Added 15.6%	70,600 $162,000
Q3 2018 Nov 14, 2018	BUY	$2.69 - $3.89 $37,444 - $54,148	13,920 Added 29.52%	61,073 $206,000
Q2 2018 Aug 14, 2018	BUY	$2.82 - $4.07 $132,971 - $191,912	47,153 New	47,153 $141,000
Q3 2017 Nov 14, 2017	SELL	$1.63 - $2.41 $3,610 - $5,338	-2,215 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	2,215	2,215 $4,000

Others Institutions Holding ATEC

# of Institutions

275

Shares Held

104M

Call Options Held

7.51M

Put Options Held

1.03M

View Full List

About Alphatec Holdings, Inc.

Ticker ATEC
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 104,656,000
Market Cap $1.41B
Description
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedic...

More about ATEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account